ICRP, 1991b. The
1990 Recommendations of the International Commission on Radiological
Protection. ICRP Publication 60. Ann. ICRP21 (1–3).
2.
ICRP, 1999b. Risk
estimation for multifactorial diseases. ICRP Publication 83.
Ann. ICRP29 (3–4).
3.
ICRP, 2003c.
Relative biological effectiveness (RBE), quality factor (Q) and
radiation weighting factor (wR). ICRP Publication 92. Ann.
ICRP33 (4).
4.
ICRP, 2005d.
Low-dose extrapolation of radiation-related cancer
risk. ICRP Publication 99. Ann. ICRP35 (4).
5.
ICRP, 2006a.
Assessing dose of the representative person for the purpose of
radiation protection of the public and The optimisation of radiological
protection: Broadening the process. ICRP Publication 101.
Ann. ICRP36 (3).
6.
ICRP, 2007b.
Radiological protection in medicine. ICRP
Publication 105. Ann. ICRP37 (5).
7.
CERRIE, 2004. Report of the
Committee Examining Radiation Risks of Internal Emitters (CERRIE).
CERRIE: London
October 2004, www.cerrie.org ISBN 0-85951-545-1.
8.
CherubiniR.GoodheadD.T.MenzelH.G. (Eds.), 2002. Proceedings of the 13th Symposium on
Microdosimetry. Radiat. Prot. Dosim. 99Nos. 1–4.
9.
CoxR.EdwardsA.A., 2002. Comments on the paper:
Microsatellite instability in acute myelocylic leukaemia developed from A-bomb
survivors and related cytogenetic data. Int. J. Radiat.
Biol. 78,
443–445.
10.
EllenderM.HarrisonJ.D.EdwardsA.A., 2005. Direct single gene mutational
events account for radiation-induced intestinal adenoma yields in Apc(min/+)
mice. Radiat. Res. 163,
552–556.
11.
GoodheadD.G.O'NeillP.MenzelH.G. (Eds.), 1996. Microdosimetry: An
interdisciplinary approach. Proceedings of the 12th Symposium on
Microdosimetry. Royal Society of Chemistry,
Cambridge.
12.
ICRP, 1991b. The
1990 Recommendations of the International Commission on Radiological
Protection. ICRP Publication 60. Ann. ICRP21 (1–3).
13.
ICRP, 1998a. Genetic
susceptibility to cancer. ICRP Publication 79. Ann.
ICRP, 28 (1/2).
14.
ICRP, 2003c.
Relative biological effectiveness (RBE), quality factor (Q) and
radiation weighting factor (wR). ICRP Publication 92. Ann.
ICRP33 (4).
15.
ICRP, 2005d.
Low-dose extrapolation of radiation-related cancer
risk. ICRP Publication 99. Ann. ICRP35 (4).
16.
IzumiS.SuyamaA.KoyamaK., 2003a. Radiation-related mortality among
offspring of atomic bomb survivors after a half-century of
follow-up. Int. J. Cancer107, 291–297.
17.
IzumiS.KoyamaK.SodaM., 2003b. Cancer incidence in children and
young adults did not increase relative to parental exposure to atomic
bombs. Br. J. Cancer89, 1709–1713.
18.
LittleJ.B., 2003. Genomic instability and bystander
effects: a historical perspective. Oncogene22, 6978–6987.
19.
LohrerH.D.BraselmannH.RichterH.E., 2001. Instability of microsatellites in
radiation-associated thyroid tumours with short latency periods.
Int. J. Radiat. Biol. 77,
891–899.
20.
MorganW.F., 2003. Non-targeted and delayed effects
of exposure to ionizing radiation: I Radiation-induced genomic instability and
bystander effects in vitro. Radiat. Res.
159, 567–580.
21.
MothersillC.SeymourC., 2001. Radiation-induced bystander
effects: Past history and future directions. Radiat.
Res. 155,
759–767.
22.
NakanishiM.TanakaK.TakahashiT., 2001. Microsatellite instability in
acute myelocytic leukaemia developed from A-bomb survivors.
Int. J. Radiat. Biol. 77:
687–694 and Comments (2002), Int. J. Radiat. Biol.
78, 441–445.
23.
NAS/NRC, 2006. Health Risks
from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2. Board on
Radiation Effects Research. National Research Council of
the National Academies, Washington,
D.C..
24.
NCRP, 2001. Evaluation of
the Linear-Non-threshold Dose-Response Model for Ionizing Radiation. NCRP
Report No. 36. National Council on Radiation Protection and
Measurements, Bethesda,
MD.
25.
TawnE.J.WhitehouseC.A.TaroneR.E., 2004. FISH Chromosome analysis of
retired radiation workers from the Sellafield nuclear facility.
Radiat. Res. 162,
249–256.
26.
ThackerJ.NygaardO.F.SinclairW.K., 1992. Radiation induced mutation in mammalian
cells at low doses and dose rates. Advances in Radiation Biology,
Vol. 16. Academic Press Inc,
New York, NY, pp.
77–124.
27.
TuckerJ.D.TawnE.J.HoldsworthD., 1997. Biological dosimetry of radiation
workers at the Sellafield nuclear facility. Radiat.
Res. 148,
216–226.
28.
UNSCEAR, 1993. United
Nations Scientific Committee on the Effects of Atomic Radiation. Sources
and Effects of Ionizing Radiation. 1993 Report to the General Assembly with
Scientific Annexes, United Nations,
New York.
29.
UNSCEAR, 1994. United
Nations Scientific Committee on the Effects of Atomic Radiation.
Sources and Effects of Ionizing Radiation. 1994
Report to the General Assembly with Scientific Annexes, United Nations, New
York.
30.
UNSCEAR, 2000. United
Nations Scientific Committee on the Effects of Atomic Radiation.
Sources and Effects of Ionizing Radiation. Vol.
II Effects. 2000 Report to the General Assembly with Scientific Annexes, United
Nations, New York.
31.
UNSCEAR, 2001. United
Nations Scientific Committee on the Effects of Atomic Radiation.
Heritable Effects of Radiation. 2001 Report to
the General Assembly with Scientific Annex, United Nations, New
York.
32.
AFRRI Contract Report 94-1, 1994.
Analysis of chronic radiation sickness cases in the population of the
Southern Urals. AFRRI,
Bethesda, Maryland, USA.
33.
AFRRI Contract Report 98-1, 1998.
Chronic radiation sickness among Techa Riverside Residents.
AFRRI, Bethesda, Maryland,
USA.
34.
AkleyevA.V.KisselyovM.F. (Eds.), 2002. Medical-biological and ecological
impacts of radioactive contamination of the Techa river.
Fregat,
Chelyabinsk. ISBN5-88931-026-7.
35.
AkleyevA.VeremeyevaG.A.SilkinaL.A., 1999. Long-term hemopoiesis and immunity
status after chronic radiation exposure of red bone marrow in
humans. Central European Journal of Occ. and Env.
Medicine5, 113–129.
36.
DörrW.HendryJ.H., 2001. Consequential late effects in
normal tissues. Radiother. Oncol.
61, 223–231.
37.
EdwardsA.A.LloydD.C., 1996. Risk from deterministic effects of
ionising radiation. Doc. NRPBVol. 7No.3.
38.
GuskovaA.K.GusevI.A.OkladnikovaN.D., 2002. Russian concepts of chronic
radiation disease in man. Br. J. Radiol. Supp.
26, 19–23.
39.
HallP.GranathF.LundellM., 1999. Lenticular opacities in
individuals exposed to ionising radiation in infancy.
Radiat. Res. 152,
190–195.
40.
HendryJ.H., 1994. Biological response modifiers and
normal tissue injury after irradiation. Seminars in
Radiation Oncology4, 123–132.
41.
HendryJ.H.ThamesH.D., 1987. Fractionation in Radiotherapy.
Taylor and Francis,
London.
42.
ICRP, 1984.
Non-stochastic effects of irradiation. ICRP
Publication 41. Ann. ICRP14 (3).
43.
ICRP, 1989b. RBE for
deterministic effects. ICRP Publication 58. Ann.
ICRP20 (4).
44.
ICRP, 1991b. The
1990 Recommendations of the International Commission on Radiological
Protection. ICRP Publication 60. Ann. ICRP21 (1–3).
45.
ICRP, 2003a.
Biological effects after prenatal irradiation (embryo and
fetus). ICRP Publication 90. Ann. ICRP33 (1/2).
46.
JoinerM.C.MarplesB.LambinP., 2001. Low-dose hypersensitivity: current
status and possible mechanisms. Int. J. Radiat. Oncol.
Biol. Phys. 49,
379–389.
47.
JungH.Beck-BornholdtH.P.SvobodaV., 2001. Quantification of late
complications after radiation therapy. Radiother.
Oncol. 61,
233–246.
48.
LefaixJ.L.DelanianS.LeplatJ.J., 1996. Successful treatment of
radiation-induced fibrosis using Cu/Zn-SOD and Mn-SOD: an experimental
study. Int. J. Radiat. Oncol. Biol. Phys.
35, 305–312.
49.
MichalowskiA., 1981. Effects of radiation on normal
tissues: hypothetical mechanisms and limitations of in situ assays of
clonogenicity. Radiat. Environ. Biophys.
19, 157–172.
50.
MinamotoA.TaniguchiH.YoshitaniN., 2004. Cataracts in atomic bomb
survivors. Int. J. Radiat. Biol.
80, 339–345.
51.
NCRP, 1974. Radiological
factors affecting decision-making in a nuclear attack. Report No. 42.
National Council on Radiation Protection and
Measurements, Bethesda,
MD.
52.
NCRP, 1989. Radiation
protection for medical and allied health personnel. Report No. 105.
National Council on Radiation Protection and
Measurements, Bethesda,
MD.
53.
NUREG, 1997. Probabilistic
accident consequence uncertainty analysis — Early health effects uncertainty
assessment. CR-6545/EUR 16775. US Nuclear Regulatory
Commission, Washington DC, USA,
and Commission of the European Communities, Brussels, Belgium.
54.
OkunieffP.MesterM.WangJ., 1998. In-vivo radioprotective effects of
angiogenic growth factors on the small bowel of C3H mice.
Radiat. Res. 150,
204–211.
55.
OtakeM.SchullW.J., 1990. Radiation-related posterior
lenticular opacities in Hiroshima and Nagasaki atomic bomb survivors based on the
DS86 dosimetry system. Radiat. Res.
121, 3–31.
56.
RubinP.FinklesteinJ.N.WilliamsJ.P., 1998. Paradigm shifts in the radiation
pathophysiology of late effects in normal tissues: molecular vs classical
concepts. In: TobiasJ.S.ThomasP.R.M. (Eds) Current Radiation OncologyVol 3. Arnold,
London.
57.
ScottB.R., 1993. Early occurring and continuing
effects. In: Modification of models resulting from
addition of effects of exposure to alpha-emitting nuclides.
Washington, D.C., Nuclear
Regulatory Commission, NUREG/CR-4214, Rev 1, Part II, Addendum 2
(LMF-136).
58.
ScottB.R.HahnF.F., 1989. Early occurring and continuing effects
models for nuclear power plantaccident consequence analysis.
Low-LET radiation. Washington
DC, Nuclear Regulatory Commission, NUREG/CR-4214 (SAND85-7185)
Rev. 1, Part II.
59.
UNSCEAR, 1988. United
Nations Scientific Committee on the Effects of Atomic Radiation. Sources, Effects
and Risks of Ionizing Radiation. 1988 Report to the General Assembly with
Annexes, United Nations, New
York.
60.
van der KogelA.J., 2002. Radiation response and tolerance
of normal tissues. In: Basic Clinical
Radiobiology. SteelG.G. (Ed). Arnold,
London.
61.
WangJ.AlbertsonC.M.ZhengH., 2002. Short-term inhibition of
ADP-induced platelet aggregation by clopidogrel ameliorates radiation-induced
toxicity in rat small intestine. Thromb. Haemost.
87, 122–128.
62.
WheldonT.E.MichalowskiA.S.KirkJ., 1982. The effect of irradiation on
function in self-renewing normal tissues with differing proliferative
organisation. Br. J. Radiol. 55,
759–766.
63.
WithersH.R.TaylorJ.M.MaciejewskiB., 1988. Treatment volume and tissue
tolerance. Int. J. Radiat. Oncol. Biol. Phys.
14, 751–759.
64.
CardisE.VrijheidM.BlettnerM., 2005. Risk of cancer after low doses of
ionising radiation: retrospective cohort study in 145 countries.
Br. Med. J. 331,
77–80.
65.
CERRIE, 2004. Report of the
Committee Examining Radiation Risks of Internal Emitters (CERRIE).
CERRIE: London
October 2004, www.cerrie.org ISBN 0-85951-545-1.
66.
DarbyS.HillD.AuvinenA., 2005. Radon in homes and risk of lung
cancer: collaborative analysis of individual data from 13 European case-control
studies. Br. Med. J. 330,
223–226.
67.
EPA, 1999. Estimating
Radiogenic Cancer Risks. Environmental Protection Agency Report
402-R-00-003, Washington DC.
IARC, 2000. IARC monographs
on the evaluation of carcinogenic risks to humans. Ionizing radiation,
Part I: X and gamma radiation and neutrons, vol. 75.
IARC Press,
Lyon.
70.
IARC, 2001. IARC
monographs on the evaluation of carcinogenic risks to humans.
Ionizing radiation, Part 2: some internally deposited
radionuclides, vol. 78. IARC
Press, Lyon.
71.
ICRP, 1991a. The
biological basis for dose limitation in the skin. ICRP Publication
59. Ann. ICRP22 (2).
72.
ICRP, 1991b. The
1990 Recommendations of the International Commission on Radiological
Protection. ICRP Publication 60. Ann. ICRP21 (1–3).
73.
ICRP, 1998a. Genetic
susceptibility to cancer. ICRP Publication 79. Ann.
ICRP28 (1/2).
74.
ICRP, 2003a.
Biological effects after prenatal irradiation (embryo and
fetus). ICRP Publication 90. Ann. ICRP33 (1/2).
75.
ICRP, 2003c.
Relative biological effectiveness (RBE), quality factor (Q) and
radiation weighting factor (wR). ICRP Publication 92. Ann.
ICRP33 (4).
76.
ICRP, 2005d.
Low-dose extrapolation of radiation-related cancer
risk. ICRP Publication 99. Ann. ICRP35 (4).
77.
KrewskiD.LubinJ.H.ZielinskiJ.M., 2005. Residential radon and risk of lung
cancer: a combined analysis of seven North American case-control
studies. Epidemiology16, 137–145.
78.
LandC.E.HayakawaN.MachadoS.G., 1994. A case-control interview study of
breast cancer among Japanese A-bomb survivors. II. Interactions with radiation
dose. Cancer Causes Control5, 167–76.
79.
LandC.E.SinclairW.K., 1991. The relative contributions of
different organ sites to the total cancer mortality associated with low-dose
radiation exposure. Ann ICRP22, 31–57.
80.
LubinJ.H.BoiceJ.D.JrEdlingC., 1995. Lung cancer in radon-exposed
miners and estimation of risk from indoor exposure. J.
Natl Cancer. Inst. 87,
817–827.
81.
LubinJ.H.WangZ.Y.BoiceJ.D.Jr, 2004. Risk of lung cancer and
residential radon in China: pooled results of two studies.
Int. J. Cancer, 109,
132–7.
82.
MitchelR.E.JacksonJ.S.McCannR.A., 1999. The adaptive response modifies
latency for radiation-induced myeloid leukaemia in CBA/H mice.
Radiat. Res. 152,
273–279.
83.
MitchelR.E.JacksonJ.S.MorrisonD.P., 2003. Low doses of radiation increase
the latency of spontaneous lymphomas and spinal osteosarcomas in cancer-prone,
radiation-sensitive Trp53 heterozygous mice. Radiat.
Res. 159,
320–327.
84.
NAS/NRC, 2006.
Health Risks from Exposure to Low Levels of Ionizing Radiation:
BEIR VII Phase 2. Board on Radiation Effects
Research. National Research Council of the National
Academies, Washington,
D.C..
85.
NCI/CDC, 2003. Report of
the NCI-CDC Working Group to revise the 1985 NIH Radioepidemiological
Tables. US Department of Health and Human Services,
National Institutes of Health, National Cancer Institute,
Bethesda, Maryland, NIH Publication No.
03–5387.
86.
NCRP, 1997. Uncertainties
in Fatal Cancer Risk Estimates Used in Radiation Protection. NCRP Report
No. 126. National Council on Radiation Protection and
Measurements, Bethesda,
MD.
87.
NCRP, 2001. Evaluation of
the Linear-Non-threshold Dose-Response Model for Ionizing Radiation. NCRP
Report No. 36. National Council on Radiation Protection and
Measurements, Bethesda,
MD.
88.
ParkinD.M.WhelanS.L.FerlayJ. (Eds.), 2002. Cancer Incidence in Five
Continents Vol VIII. IARC Scientific Publications No. 155.
Lyon International Agency for Research on
Cancer.
89.
PierceD.A.SharpG.B.MabuchiK., 2003. Joint effects of radiation and
smoking on lung cancer risk among atomic bomb survivors.
Radiat. Res. 159,
511–520.
90.
PierceD.A.StramD.O.VaethM., 1990. Allowing for random errors in
radiation dose estimates for the atomic bomb survivor data.
Radiat. Res. 123,
275–284.
91.
PrestonD.L.KusumiS.TomonagaM., 1994. Cancer incidence in atomic bomb
survivors. Part III. Leukaemia, lymphoma and multiple myeloma,
1950–1987. Radiat. Res. 137,
S68–97.
92.
PrestonD.L.MattssonA.HolmbergE., 2002. Radiation effects on breast cancer
risk: a pooled analysis of eight cohorts. Radiat.
Res. 158,
220–235.
93.
PrestonD.L.ShimizuY.PierceD.A.2003. Studies of mortality of atomic bomb survivors.
Report 13: Solid cancer and non-cancer disease mortality
1950–1997. Radiat. Res. 160,
381–407.
94.
PrestonD.L.PierceD.A.ShimizuY., 2004. Effect of recent changes in atomic
bomb survivor dosimetry on cancer mortality risk estimates.
Radiat. Res. 162,
377–389.
95.
PrestonD.L.RonE.TokuokaS., 2007. Solid cancer incidence in atomic
bomb survivors: 1958–98. Radiat. Res.
168, 1–64.
96.
PuskinJ.S.NelsonN.S.NelsonC.B., 1992. Bone cancer risk
estimates. Health Phys. 63,
579–580.
97.
RonE.LubinJ.H.ShoreR.E., 1995. Thyroid cancer after exposure to
external radiation: a pooled analysis of seven studies.
Radiat. Res. 141,
259–277.
98.
RonE.PrestonD.L.KishikawaM., 1998. Skin tumor risk among atomic-bomb
survivors in Japan. Cancer Causes Control9, 393–401.
99.
SharpG.B.MizunoT.CologneJ.B., 2003. Hepatocellular carcinoma among
atomic bomb survivors: significant interaction of radiation with hepatitis C virus
infections. Int. J. Cancer103, 531–537.
100.
ThompsonD.E.MabuchiK.RonE., 1994. Cancer Incidence in atomic bomb
survivors. Part II: Solid tumours, 1958–1987. Radiat.
Res. 137,
S17–67.
101.
TravisL.B.GospodarowiczM.CurtisR.E., 2002. Lung cancer following chemotherapy
and radiotherapy for Hodgkin's disease. J. Natl Cancer
Inst. 94,
182–192.
102.
UNSCEAR, 1993.
United Nations Scientific Committee on the Effects of Atomic
Radiation. Sources and Effects of Ionizing
Radiation. 1993 Report to the General Assembly with Scientific Annexes,
United Nations, New
York.
103.
UNSCEAR, 1994.
United Nations Scientific Committee on the Effects of Atomic
Radiation. Sources and Effects of Ionizing
Radiation. 1994 Report to the General Assembly with Scientific Annexes,
United Nations, New
York.
104.
UNSCEAR, 2000.
United Nations Scientific Committee on the Effects of Atomic
Radiation. Sources and Effects of Ionizing
Radiation. Vol. II Effects. 2000 Report to the General
Assembly with Scientific Annexes, United Nations,
New York.
105.
UNSCEAR, 2001. United
Nations Scientific Committee on the Effects of Atomic Radiation.
Heritable Effects of Radiation., 2001 Report to the General Assembly with Scientific
Annex, United Nations, New
York.
106.
AlemanB.M.van den Belt-DuseboutA.W.KlokmanW.J., 2003. Long-term cause-specific mortality
of patients treated for Hodgkin's disease. J. Clin.
Oncol. 21,
3431–3439.
107.
Early Breast Cancer Trialists' Collaborative
Group, 2000. Favourable and unfavourable
effects on long-term survival of radiotherapy for early breast cancer: an overview
of the randomised trials. Lancet355, 1757–1770.
108.
HancockS.L.TuckerM.A.HoppeR.T., 1993. Factors affecting late mortality
from heart disease after treatment of Hodgkin's disease.
J. Am. Med. Assoc. 270,
1949–55.
109.
HayashiT.KusunokiY.HakodaM., 2003. Radiation dose-dependent increases
in inflammatory response markers in A-bomb survivors. Int.
J. Radiat. Biol. 79,
129–36.
110.
McGaleP.DarbyS.C., 2005. Low doses of ionizing radiation
and circulatory diseases: A systematic review of the published epidemiological
evidence. Radiat Res. 163,
247–257.
111.
PrestonD.L.ShimizuY.PierceD.A.2003. Studies of mortality of atomic bomb
survivors. Report 13: Solid cancer and non-cancer disease
mortality 1950–1997. Radiat. Res. 160,
381–407.
112.
UNSCEAR, 2008. Effects of
Ionizing Radiation. United Nations Scientific Committee on the Effects of
Atomic Radiation Report to the General Assembly with Scientific Annexes.
United Nations, New York,
NY.
113.
BrewerC.HollowayS.ZawalnyskiP., 1998. A chromosomal deletion map of
human malformations. Am. J. Hum. Genet.
63, 1153–1159.
114.
CarterC.O., 1961. The inheritance of pyloric
stenosis. Brit. Med. Bull. 17,
251–254.
115.
CarterC.O., 1977. Monogenic
disorders. J. Med. Genet. 14,
316–320.
116.
CattanachB.M.BurtenshawM.D.RasberryC., 1993. Large deletions and other gross
forms of chromosome imbalance compatible with viability and fertility in the
mouse. Nature Genet. 3,
56–61.
117.
CattanachB.M.EvansE.P.RasberryC., 1996. Incidence and distribution of
radiation-induced large deletions in the mouse. In: HagenU.HarderD.JungH. (Eds). Congress Proceedings, Tenth Int. Cong. Radiat. Res., Würzburg,
Germany, Vol. 2,
531–534.
118.
ChakrabortyR.YasudaN.DennistonC.SankaranarayananK., 1998. Ionizing radiation and genetic
risks. VII. The concept of mutation component and its use in risk estimation for
mendelian diseases. Mutat. Res.
400, 41–52.
119.
CrowJ.F.DennistonC., 1981. The mutation component of genetic
damage. Science212, 888–893.
120.
CrowJ.F.DennistonC., 1985. Mutation in human
populations. In: HarrisH.HirschhornH. (Eds.), Adv. Hum. Genet., Vol. 12.
Plenum Press, N.Y,
pp. 59–123.
121.
CzeizelA.SankaranarayananK., 1984. The load of genetic and partially
genetic disorders in man. I. Congenital anomalies: estimates of detriment in terms
of years lost and years of impaired life. Mutat.
Res. 128,
73–103.
122.
CzeizelA.SankaranarayananK.LosonciA., 1988. The load of genetic and partially
genetic disorders in man. II. Some selected common multifactorial diseases.
Estimates of population prevalence and of detriment in terms of years lost and
impaired life. Mutat. Res. 196,
259–292.
123.
DennistonC.ChakrabortyR.SankaranarayananK., 1998. Ionizing radiation and genetic
risks. VIII. The concept of mutation component and its use in risk estimation for
multifactorial diseases. Mutat. Res.
405, 7–79.
124.
EhlingU.H., 1965. The frequency of X-ray-induced
dominant mutations affecting the skeleton in mice.
Genetics51, 723–732.
125.
EhlingU.H., 1966. Dominant mutations affecting the
skeleton in offspring of X-irradiated male mice.
Genetics54, 1381–1389.
126.
FalconerD.S., 1960. Introduction to Quantitative
Genetics. Oliver and Boyd, Edinburgh. Falconer, D.S., 1965. The
inheritance of liability to certain diseases, estimated from the incidence among
relatives. Ann. Hum. Genet. (Lond)29, 51–76.
127.
FavorJ., 1989. Risk estimation based on germ cell
mutations in animals. Genome31, 844–852.
128.
GreenE.L., 1968. Genetic effects of radiation on
mammalian populations. Ann. Rev. Genet.
2, 87–120.
129.
ICRP, 1991b. The
1990 Recommendations of the International Commission on Radiological
Protection. ICRP Publication 60. Ann. ICRP21 (1–3).
130.
ICRP, 1998a. Genetic
susceptibility to cancer. ICRP Publication 79. Ann.
ICRP28 (1/2).
131.
ICRP, 1999b. Risk
estimation for multifactorial diseases. ICRP Publication 83.
Ann. ICRP29 (3–4).
132.
KirkK.M.LyonM.F., 1984. Induction of congenital
abnormalities in the offspring of male mice treated with x rays at pre-meiotic and
post-meiotic stages. Mutat. Res.
125, 75–85.
133.
LyonM.F.RenshawR., 1988. Induction of congenital
malformation in mice by parental irradiation: transmission to later
generations. Mutat. Res. 198,
277–283.
134.
NAS/NRC, 2006.
Health Risks from Exposure to Low Levels of Ionizing Radiation:
BEIR VII Phase 2. Board on Radiation Effects
Research. National Research Council of the National
Academies, Washington,
D.C..
135.
NomuraT., 1982. Parental exposure to X-rays and
chemicals induces heritable tumors and anomalies in mice.
Nature296, 575–577.
136.
NomuraT., 1988. X-ray and chemically induced germ
line mutations causing phenotypic anomalies in mice.
Mutat. Res. 198,
309–320.
137.
NomuraT., 1994. Male-mediated teratogenesis:
ionizing radiation and ethylnitrosourea studies. In: MattisonD.R.OlshanA.F. (Eds.), Male-mediated Developmental Toxicity.
Plenum Press, New
York, pp. 117–127.
138.
NRC, 1972. National Academy
of Sciences-National Research Council, The BEIR Report.
National Academy Press,
Washington, D.C..
139.
NRC, 1990. National Academy
of Sciences-National Research Council, The BEIR V Report.
National Academy Press,
Washington, D.C..
140.
SankaranarayananK., 1991. Genetic effects of ionising
radiation in man. Ann. ICRP22, 76–94.
141.
SankaranarayananK., 1998. Ionizing radiation and genetic
risks. IX. Estimates of the frequencies of mendelian diseases and spontaneous
mutation rates in human populations: a 1998 perspective.
Mutat.Res. 411,
129–178.
142.
SankaranarayananK., 1999. Ionizing radiation and genetic
risks. X. The potential ‘disease phenotypes’ of radiation-induced genetic damage
in humans: perspectives from human molecular biology and radiation
genetics. Mutat. Res. 429,
45–83.
143.
SankaranarayananK.ChakrabortyR., 2000a. Ionizing radiation and genetic
risks. XI. The doubling-dose estimates from the mid 1950s to the present, and the
conceptual change to the use of human data on spontaneous mutation rates and mouse
data on induced mutation rates for doubling-dose calculations.
Mutat. Res. 453,
107–127.
144.
SankaranarayananK.ChakrabortyR., 2000b. Ionizing radiation and genetic
risks. XII. The concept of ‘potential recoverability correction factor’ (PRCF) and
its use for predicting the risk of radiationinducible genetic disease in human
live births. Mutat. Res. 453,
129–181.
145.
SankaranarayananK.ChakrabortyR., 2000c. Ionizing radiation and genetic
risks. XIII. Summary and synthesis of papers VI to XII and estimates of genetic
risks in the year 2000. Mutat. Res.
453, 183–197.
146.
SankaranarayananK.ChakrabortyR.BoerwinkleE.A., 1999. Ionizing radiation and genetic
risks. VI. Chronic multifactorial diseases: a review of epidemiological and
genetic aspects of coronary heart disease, essential hypertension and diabetes
mellitus. Mutat. Res. 436,
21–57.
147.
SankaranarayananK.YasudaN.ChakrabortyR., 1994. Ionizing radiation and genetic
risks. V. Multifactorial diseases: a review of epidemiological and genetic aspects
of congenital abnormalities in man and of models on maintenance of quantitative
traits in populations. Mutat. Res.
317, 1–23.
148.
SearleA.G.BeecheyC.V., 1986. The role of dominant visibles in
mutagenicity testing. In: RamelC. (Eds). Genetic Toxicology of Environmental Chemicals, Part B,
Genetic Effects and Applied Mutagenesis. Alan R.
Liss, New York, NY,
511–518.
149.
SelbyP.B., 1998. Discovery of numerous clusters of
spontaneous mutations in the specific locus test in mice necessitates major
increases in estimates of doubling doses.
Genetica (102/103),
463–487.
150.
SelbyP.B.SelbyP.R., 1977. Gamma-ray-induced dominant
mutations that cause skeletal abnormalities in mice. I. Plan, summary of results
and discussion. Mutat. Res. 43,
357–375.
151.
UNSCEAR, 1972.
United Nations Scientific Committee on the Effects of Atomic
Radiation. Sources and lEffects of Ionizing
Radiation. 1972 Report to the General Assembly with Annexes,
United Nations, New
York.
152.
UNSCEAR, 1977.
United Nations Scientific Committee on the Effects of Atomic
Radiation. Sources and Effects of Ionizing
Radiation. 1977 Report to the General Assembly with Annexes,
United Nations, New
York.
153.
UNSCEAR, 1988.
United Nations Scientific Committee on the Effects of Atomic
Radiation. Sources, Effects and Risks of Ionizing
Radiation. 1988 Report to the General Assembly with Annexes,
United Nations, New
York.
154.
UNSCEAR, 1993.
United Nations Scientific Committee on the Effects of Atomic
Radiation. Sources and Effects of Ionizing
Radiation. 1993 Report to the General Assembly with Scientific Annexes,
United Nations, New
York.
155.
UNSCEAR2001. United Nations Scientific Committee on the Effects of
Atomic Radiation. Heritable Effects of Radiation., 2001 Report to the
General Assembly with Scientific Annex, United
Nations, New
York.
156.
ICRP, 1991b. The
1990 Recommendations of the International Commission on Radiological
Protection. ICRP Publication 60. Ann. ICRP21 (1–3).
157.
ICRP1998a. Genetic susceptibility to cancer.
ICRP Publication 79. Ann. ICRP28 (1/2).
158.
ICRP2003c. Relative biological effectiveness (RBE), quality
factor (Q) and radiation weighting factor (wR). ICRP Publication
92. Ann. ICRP33 (4).
159.
ICRP, 2005d.
Low-dose extrapolation of radiation-related cancer
risk. ICRP Publication 99. Ann. ICRP35 (4).
160.
NAS/NRC, 2006.
Health Risks from Exposure to Low Levels of Ionizing Radiation:
BEIR VII Phase 2. Board on Radiation Effects
Research. National Research Council of the National
Academies, Washington,
D.C..
161.
NCRP, 2001. Evaluation of
the Linear-Non-threshold Dose-Response Model for Ionizing Radiation. NCRP
Report No. 36. National Council on Radiation Protection and
Measurements, Bethesda,
MD.
162.
UNSCEAR, 1994.
United Nations Scientific Committee on the Effects of Atomic
Radiation. Sources and Effects of Ionizing
Radiation. 1994 Report to the General Assembly with Scientific Annexes,
United Nations, New
York.
163.
UNSCEAR, 2000.
United Nations Scientific Committee on the Effects of Atomic
Radiation. Sources and Effects of Ionizing
Radiation. Vol. II Effects. 2000 Report to the General Assembly with
Scientific Annexes, United Nations,
New York.
164.
UNSCEAR, 2001.
United Nations Scientific Committee on the Effects of Atomic
Radiation. Heritable Effects of Radiation., 2001
Report to the General Assembly with Scientific Annex, United
Nations, New
York.
